MedTrace Logo

Testing New Method of Analyzing MR Images

NCT00630318 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-01-12

No results posted yet for this study

Summary

Preliminary imaging study to test for future use of this MRI-imaging for evaluating anti-angiogenesis treatment.

Conditions

  • Breast Abnormalities

Interventions

DEVICE

MRI

15-20 minutes MR imaging

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Susan E. Clare, MD, Ph.D. · Indiana University

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00630318 on ClinicalTrials.gov